Helicobacter pylori infection is associated with advanced colorectal neoplasia

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 1, 2014, Pages 35-42

  Shmuely, Haim ^a   Melzer, Ehud ^b   Braverman, Michal ^b   Domniz, Noam ^a   Yahav, Jacob ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Advanced neoplasia; Colorectal cancer; Colorectal neoplasia; Helicobacter pylori

Indexed keywords

CAGA PROTEIN; IMMUNOGLOBULIN G ANTIBODY;

ADENOMATOUS POLYP; ADULT; ADVANCED CANCER; ARTICLE; COLONOSCOPE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; COLORECTAL TUMOR; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PANCOLONOSCOPY; PREVALENCE; PRIORITY JOURNAL; WESTERN BLOTTING;

ADENOMA; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; ISRAEL; MALE; MIDDLE AGED; PREVALENCE; SEROLOGIC TESTS;

EID: 84890932458     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.848468     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61: 69-90
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;15: 2893-917
3. Senter L. Genetic testing by cancer site: Colon (nonpolyposis syndromes). Cancer J 2012;18: 334-7
4. Kaz AM, Brentnall TA. Genetic testing for colon cancer. Nat Clin Pract Gastroenterol Hepatol 2006;3: 670-9
5. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, et al. The annual report to the natioNon the status of cancer, 1973-1997, with a special sectioNon colorectal cancer. Cancer 2000;88: 2398-424
6. Go MF. Review article: Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol 2002;1: 3-15
7. Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, et al. Age at acquisition of H. pylori infection: A follow up study from infancy to adult hood. Lancet 2002;359: 931-5
8. Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, et al. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 1997;24: 605-7
9. ShmuelyH, Passaro D, Figer A,Niv Y, Pitlik S, Samra Z, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001;96: 3406-10
10. Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA. Helicobacter pylori seroprevalence and colorectal neoplasia evidence against an association. J Natl Cancer Inst 1995;87: 762-3
11. Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol 2001; 96: 84-8
12. Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A. Helicobacter pylori: Seroprevalence and colorectal cancer. Isr Med Assoc J 2000;2: 6-9
13. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection colorectal cancer risk: A meta-analysis. Helicobacter 2006;11: 75-80
14. Hong SN, Lee SM, Kim JH, Lee TY, Kim JH, Choe WH, et al. Helicobacter pylori infection increases the risk of colorectal adenomas: Cross-sectional study and meta-analysis. Dig Dis Sci 2012;57: 2184-94
15. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterol 1987;93: 1009-13
16. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, et al. Colonoscopy in colorectalcancer screening for detection of advanced neoplasia. N Engl J Med 2006;355: 1863-72
17. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps: The national polyp study workgroup. N Engl J Med 1993;328: 901-6
18. Yahav J, Fradkin A, Weisselberg B, Diver-Haver A, Shmuely H, Jonas A. Relevance of CagA positivity to clinical course of Helicobacter pylori infection in children. J Clin Microbial 2000;38: 3534-7
19. Shmuely H, Passaro DJ, Vaturi M, Sagie A, Pitlik S, Samra Z, et al. Association of CagA+Helicobacter pylori infection with aortic atheroma. Atherosclerosis 2005;179: 127-32
20. den Hoed CM, Vila AJ, Holster IL, et al. Helicobacter pylori and the birth cohort effect: Evidence for stabilized colonization rates in childhood. Helicobacter 2011;16: 405-9
21. Grossman S, Milos ML, Tekawa IS, Jewell NP. Colonoscopic screening of persons with suspected risk factors for colon cancer: II. Past history of colorectal neoplasms. Gastroenterology 1989;96: 299-306
22. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34: 1672-6
23. Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013; 108: 208-15
24. Von Wulffen H. An assessment of serological tests for detection of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992;11: 577-82
25. Morris AJ, Ali MR, Nicolson GI, Perez-Perez GI, Blaser MJ. Long-term follow-up of voluntary ingestion of Helicobacter pylori. Ann Intern Med 1991;114: 662-3
26. Perez-Perez GI, Dworkin B, Chodos J, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 1988; 109: 11-17
27. Karnes WE, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with chronic atrophic body gastritis. Gastroenterology 1991;101: 167-74
28. Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 1999;282: 2240-5
29. Thomas JE, Gibson GR, Darboe MK, Dale A, Weavaer LT. Isolation of Helicobacter pylori from human faeces. Lancet 1992;340: 1194-5
30. Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal cancer. Lancet Oncol 2011;12: 504-12
31. Takeda H, Asaka M. Helicobacter pylori and colorectal neoplasm: A mysterious link? J Gastroenterol 2005;40: 919-20
32. Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: Influence of age, gender, and family history. Am J Gastroenterol 1993;88: 825-31
33. Johnson DA, Gurney MS, Volpe RJ, Jones DM, VanNess MM, Chobanian SJ, et al. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol 1990; 85: 969-74
34. Darwish H, Trejo IE, Shapira I, Oweineh S, Sughayer M, Baron L, et al. Fighting colorectal cancer: Molecular epidemiology differences among Ashkenazi and Sephardic Jews and Palestinians. AnNoncol 2002;13: 1497-501
35. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: A prospective study. Gastroenterology 1998;115: 275-80
36. Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, et al. Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control 2010; 21: 163-70